DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

Mallinckrodt plc (NYSE: MNK)



company name or ticker
Company Photos
(Click to zoom)

Mallinckrodt Launches Notes Offering

Corcept's Warrants Exercised, Invest in Korlym, Pipeline - Analyst Blog

Corcept's Warrants Exercised, Invest in Korlym, Pipeline - Analyst Blog

The Zacks Analyst Blog Highlights: Hewlett-Packard, Aruba Networks, Lannett, Mallinckrodt and Avago

The Zacks Analyst Blog Highlights: Hewlett-Packard, Aruba Networks, Lannett, Mallinckrodt and Avago Technologies - Press Releases

Don't Play With Propane - Cramer's Lightning Round (4/1/15)

RedHill Gets Gastrointestinal & Oncology Drug from Apogee - Analyst Blog

RedHill Gets Gastrointestinal & Oncology Drug from Apogee - Analyst Blog

Only Buy Luxury At A Deep Discount

Novartis Gets FDA Approval for Oral Formulation of Exjade - Analyst Blog

Oppenheimer: Teva Is Now Worth $77/Share, More Deals To Come

Mallinckrodt Reports Acthar Gel Data on Nephrotic Syndrome - Analyst Blog

Can Mallinckrodt public limited company (MNK) Keep the Earnings Streak Alive This Quarter? - Tale of

Can Mallinckrodt public limited company (MNK) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape
See More Articles...